737 related articles for article (PubMed ID: 28281026)
1. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
[TBL] [Abstract][Full Text] [Related]
4. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
5. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.
Nakamura D; Attizzani GF; Toma C; Sheth T; Wang W; Soud M; Aoun R; Tummala R; Leygerman M; Fares A; Mehanna E; Nishino S; Fung A; Costa MA; Bezerra HG
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582113
[TBL] [Abstract][Full Text] [Related]
6. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
[TBL] [Abstract][Full Text] [Related]
7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
8. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
11. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
12. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
Almalla M; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
[TBL] [Abstract][Full Text] [Related]
14. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.
Yonetsu T; Kato K; Kim SJ; Xing L; Jia H; McNulty I; Lee H; Zhang S; Uemura S; Jang Y; Kang SJ; Park SJ; Lee S; Yu B; Kakuta T; Jang IK
Circ Cardiovasc Imaging; 2012 Sep; 5(5):660-6. PubMed ID: 22798521
[TBL] [Abstract][Full Text] [Related]
15. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
[TBL] [Abstract][Full Text] [Related]
17. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
[TBL] [Abstract][Full Text] [Related]
18. Differences between first-generation and second-generation drug-eluting stent regarding in-stent neoatherosclerosis characteristics: an optical coherence tomography analysis.
Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Obokata M; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
Int J Cardiovasc Imaging; 2018 Oct; 34(10):1521-1528. PubMed ID: 29785558
[TBL] [Abstract][Full Text] [Related]
19. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
20. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]